Chips & deep tech · Article
Samsung and TSMC Halt Some Chip Shipments to China Under New US Rules
블루밍비트 ·

At a glance
Samsung Electronics and TSMC have stopped shipping some products to Chinese customers while they wait for US export approval. The new US rules narrow the routes Chinese firms used to get advanced chips, and smartphone chip supply may also be disrupted.
Key points
- The US tightened export controls on advanced chips made with American technology, and the new rules took effect on the 19th.
- Samsung and TSMC told Chinese clients they would halt shipments of certain processors until US approval is granted.
- TSMC now requires US export approval for orders of 16-nanometer and finer processes from restricted Chinese customers.
- Chips for smartphones and other consumer devices also now need approval, which could cause major production delays.
Why it matters
The move could limit how Chinese AI companies get advanced chips and could slow smartphone chip supply.
Original source
삼성·TSMC, 中 반도체 출하 일부 중단
블루밍비트 · Nov 20, 08:33 KST
Read on 블루밍비트 ↗AI summarized the original article. Check the original for accuracy. Copyright belongs to 블루밍비트.
Other coverage
- 포쓰저널 · 삼성전자·TSMC, 중국향 반도체 공급 일부 중단
- 뉴스핌 · FT "TSMC·삼성전자, 일부 중국 고객사에 반도체 출하 중단…美 수출 규제 여파"
- IT조선 · 삼성전자·TSMC, 중국에 일부 반도체 공급 중단
- 뉴스1 · "삼성전자·TSMC, 중국 고객사에 일부 반도체 출하 중단 통보"
- 머니투데이 · FT"삼성전자·TSMC, 중국 고객사에 반도체 출하 중단 통보" - 머니투데이
- 한국일보 · FT "삼성전자·TSMC, 중국에 반도체 일부 출하 중단"
- SBS Biz · FT 삼성전자·TSMC, 中 고객사에 반도체 출하 중단 통보
- 아이뉴스24 · 美 수출통제 강화에 삼성·TSMC, 중국행 첨단 칩 일부 출하 중단
More from this field
- Intel Lands First Outside Customer for 18A Chip Manufacturing Process
Intel said it has signed its first outside customer for its 18A manufacturing process, a sign that other companies are starting to trust its chip-making service. The company's CEO said the first contract covers a process he was personally involved in. Microsoft was also named as the first official customer for Intel's EMIB advanced packaging technology.
연합뉴스 · Nov 20, 08:08 KST - Samsung Biologics Goes Pure CDMO as Celltrion Signs 400 Billion Won Production Deal
Samsung Biologics split off its biosimilar business and now focuses purely on contract manufacturing, which has changed alliances in the bio industry. Celltrion, a long-time rival, signed a contract worth over 400 billion won with Samsung Biologics for drug production.
비즈워치 · Nov 20, 07:40 KST - Micron Plans $10 Billion Boise Research Lab as AI Raises Memory R&D Stakes
Micron Technology is building Micron Research Labs in Boise, Idaho, with a planned $10 billion investment over the next decade. The lab will look past the next chip generation and focus on future memory and manufacturing research. Groundbreaking is expected in 2027.
EE Times · Nov 20, 07:21 KST